G
Overview
OLO makes cannabis-infused sublingual strips that let users tailor their experiences. The strips dissolve under the tongue for quick absorption, offering four preset experiences (Active, Chill, Focus, Social) in 5 mg or 10 mg doses with effects starting in about 10–15 minutes. It differentiates itself through precise dosing, fast and discreet delivery, and a neuroscience-informed formulation that provides four distinct experiences. Its goal is to help people customize cannabis use with fast, predictable, and discreet dosing that fits their lifestyle.
Work here?Claim your company
Simplify's take
What believers are saying
- In April 2026, getolo expanded pet insurance into Spain, adding a new market.
- October 2026 job posts describe around 300 employees, signaling continued hiring.
- The February 2026 OP protection launch broadened pet coverage and premium yield.
What critics are saying
- Spain expansion forces new licensing, claims operations, and local acquisition before 2027.
- Reliance on Zurich and DA Direkt concentrates strategic control outside getolo’s management.
- A Zurich strategy shift can starve getolo of capital, distribution, and survival.
What makes getolo unique
- Zurich Group backs getolo, pairing startup speed with insurer balance-sheet credibility.
- DA Direkt partnership gives getolo distribution and underwriting reach in Germany.
- Its digital-only pet, dental, and supplemental health products cut paperwork and friction.
Help us improve and share your feedback! Did you find this helpful?